Apellis Pharmaceuticals

Apellis is a global biopharmaceutical company headquartered in Waltham, MA, United States. With approximately 501 employees, Apellis develops life-changing therapies by pioneering targeted C3 therapies to treat diseases driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.